GLPwatch
Trials (2139)
Page 18 of 36.
- Extension Study for 2993-112
- A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
- A Multiple Dose Study of LY3502970 in Healthy Participants
- Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
- A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
- A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
- A Research Study Looking Into Blood Levels of the Medicine NNC0480-0389 in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function
- Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients
- TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
- Evaluation of Exenatide in Patients With Diabetic Neuropathy
- Semaglutide for Smoking Cessation in Patients With Diabetes
- Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss
- A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
- Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
- Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
- GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
- Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function
- Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
- Reversal to Normoglycemia by Treating Prediabetes
- Liraglutide for Low-responders After Bariatric Surgery
- Treatment of GLP-1 for Diabetic Bariatric Patients
- Liraglutide to Improve corONary Haemodynamics During Exercise streSS
- A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes
- Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
- Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
- Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
- Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
- Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
- Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
- Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
- A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World
- A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems
- A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
- Preoperative Condition in Giant Obese Patients
- Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes
- Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
- Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
- Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)
- Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
- Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
- Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes
- A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
- Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
- Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
- A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
- Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease
- A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver
- Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
- A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
- GLP-1 and Non-exercise Activity Thermogenesis in RHZ
- A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
- A Phase 3 Study of HS-20094 in Patients With T2DM
- A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity